Blocking the P2X7 receptor improves outcomes after axonal fusion
Charles L Rodriguez-Feo1, Kevin W Sexton, Richard B Boyer
1Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA. charlie.feo@vanderbilt.edu
The Journal of Surgical Research
|June 5, 2013
Summary
Blocking the P2X7 receptor with brilliant blue (FCF) improved functional outcomes in rats following nerve repair. This P2X7 receptor inhibition enhanced polyethylene glycol (PEG)-mediated axonal fusion, offering a new therapeutic avenue for nerve injury.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Biochemistry
Background:
- Peripheral nerve injury activates P2X7 receptors, leading to calcium influx and pannexin pore formation.
- Polyethylene glycol (PEG) and methylene blue aid nerve repair by delaying Wallerian degeneration.
- Modulating P2X7 receptor activity offers a potential strategy to enhance PEG-based axonal repair.
Purpose of the Study:
- To investigate the effect of P2X7 receptor modulation on PEG-mediated axonal repair in a rat sciatic nerve injury model.
- To determine if inhibiting the P2X7 receptor pathway improves functional recovery after nerve fusion.
Main Methods:
- A rat sciatic nerve injury model was repaired using a PEG-methylene blue protocol.
- Experimental groups were treated with P2X7 receptor inhibitor (brilliant blue, FCF) or stimulator (bzATP).
- Functional recovery was assessed via electrophysiological recordings, behavioral tests, and axonal counting.
Main Results:
- FCF treatment significantly improved functional outcomes compared to controls at all time points.
- A statistical difference was observed between FCF and bzATP groups at day 7 post-injury.
- No significant difference was found between FCF and bzATP groups at days 3, 14, and 21.
Conclusions:
- Inhibition of the P2X7 receptor pathway with FCF enhances functional recovery after PEG-mediated axonal fusion.
- Targeting the P2X7 receptor represents a promising therapeutic strategy for peripheral nerve repair.
Related Concept Videos
01:29Neuromuscular Junction And Blockade
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
01:28Depolarizing Blockers: Mechanism of Action
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...